Ceo Dr. Belanoff says Corcept will make the transition to not only a research, but a commerrcial enterprise. They want to start selling their new FDA approved drug Korlym by May 1st. This company will be profitable this year. Can't wait to see what they will price this new drug at. Will be announced soon.
Does anybody have any recent info on what drugs of this type of exclusivity and patient numbers have sold for? One daily pill, I would also be interested in what is considered reasonably accepted pricing.